NOV 09, 2017 10:12 PM PST

FDA Acts on Bogus Marijuana-based Cancer Therapeutics

WRITTEN BY: Carmen Leitch
1 3 454

The U.S. Food and Drug Administration (FDA) has issued warnings because of four companies that are marketing unproven marijuana-based products as preventing, treating or even curing cancer. That is an illegal act because the claims are unsubstantiated. The FDA sent letters were sent to Greenroads Health, Natural Alchemist, That's Natural! Marketing and Consulting and Stanley Brothers Social Enterprises LLC. The products being sold online by these companies supposedly contain a chemical found in marijuana, cannabidiol (CBD), which has not been approved by the FDA as a drug product for any condition.

"Substances that contain components of marijuana will be treated like any other products that make unproven claims to shrink cancer tumors," said FDA commissioner Dr. Scott Gottlieb. "We don't let companies market products that deliberately prey on sick people with baseless claims that their substance can shrink or cure cancer and we're not going to look the other way on enforcing these principles when it comes to marijuana-containing products."

"There are a growing number of effective therapies for many cancers. When people are allowed to illegally market agents that deliver no established benefit they may steer patients away from products that have proven, anti-tumor effects that could extend lives."

Many products that contain CBD have entered the market, like teas, oils, syrups, capsules, creams, and lotions. They are being sold as therapeutics that can reverse or halt cancer, or other serious diseases including Alzheimer’s. There is, however, no evidence to back up these sweeping pronouncements that are unfortunately directed at very vulnerable people. 

Not only is the sale and marketing of these items a clear violation of the Federal Food, Drug and Cosmetic Act, it could also be putting people’s health in serious jeopardy. People may be seeking out and using these kinds of drugs instead of obtaining medical care from health professionals, which could seriously hinder a patient’s ability to get well. 

"We recognize that there's interest in developing therapies from marijuana and its components, but the safest way for this to occur is through the drug approval process -- not through unsubstantiated claims made on a website," Gottlieb said.

While marijuana may have tremendous potential as a medicinal product, the FDA wants sellers to prove their claims before peddling these products as therapeutics./Image Credit: Marijuana Wellness Products, Hollywood, Portland, Oregon / Credit: Wikimedia Commons/Another Believer

The FDA has sent over 90 letters in the past ten years to address this issue. The agency noted that over 25 products have been sold as inhibitors of “cell division and growth with certain types of cancer,” which contain a chemical that “combats tumor and cancer cells” because "CBD makes cancer cells commit suicide without killing other cells.”
 
The FDA is not against products that contain chemicals derived from marijuana; they only want to make sure they are safe and effective before being sold to people who need help. "We support sound, scientifically-based research using components derived from marijuana, and we'll continue to work with product developers who are interested in bringing safe, effective, and quality products to market,” Commissioner Gottlieb concluded.

Doctors and patients are encouraged to come forward if they have an adverse reaction, or quality issue with an “FDA-regulated drug, biologic, medical device, dietary supplement or cosmetic.” Their MedWatch program also looks for counterfeit medical devices.

Source: FDA

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JUN 12, 2018
Cancer
JUN 12, 2018
CD44 Insights & Cancer Influence
CD44 is a known cell surface protein involved in numerous interactions; it is overexpressed in cancerous tissue and its isoforms are being investigated as targets for cancer immunotherapy
JUN 22, 2018
Microbiology
JUN 22, 2018
Antiviral Compound Found in the Human Body
The human body can make a compound with a special power to fight viruses - an enzyme called viperin.
JUL 04, 2018
Cell & Molecular Biology
JUL 04, 2018
How Factors Combine to Amplify the Risk of MS
Smoking and exposure to paints had a massive impact when combined with genetic risk factors.
JUL 19, 2018
Cell & Molecular Biology
JUL 19, 2018
Stopping Structural Changes in Collagen may Prevent Lung Fibrosis
Lung fibrosis is a serious condition that thickens tissues in the lungs and makes it hard to breathe.
JUL 22, 2018
Cell & Molecular Biology
JUL 22, 2018
Using Nanosubmarines to Fight Tumors and Headaches
Researchers are getting closer to creating targeted therapies that are delivered directly where needed.
AUG 12, 2018
Cell & Molecular Biology
AUG 12, 2018
A Small Set of Cells Acts as a Timekeeper
Humans have adjusted to a daily rhythm, and our bodies rely on timing.
Loading Comments...